The temporal evolution of antidrug antibodies in patients with inflammatory bowel disease treated with infliximab

Bella Ungar; Yehuda Chowers; Miri Yavzori; Orit Picard; Ella Fudim; Ofir Har-Noy; Uri Kopylov; Rami Eliakim; Shomron Ben-Horin; on behalf of ABIRISK consortium

doi:10.1136/gutjnl-2013-305259

Article info

Inflammatory bowel disease

Original article

The temporal evolution of antidrug antibodies in patients with inflammatory bowel disease treated with infliximab

Authors

Bella Ungar Department of Gastroenterology, Sheba Medical Center Tel Hashomer & Sackler School of Medicine, Tel-Aviv University, Ramat Gan, Israel PubMed articles Google scholar articles
Yehuda Chowers Department of Gastroenterology, Rambam Health Care Campus & Bruce Rappaport School of Medicine, Technion Institute of Technology, Haifa, Israel PubMed articles Google scholar articles
Miri Yavzori Department of Gastroenterology, Sheba Medical Center Tel Hashomer & Sackler School of Medicine, Tel-Aviv University, Ramat Gan, Israel PubMed articles Google scholar articles
Orit Picard Department of Gastroenterology, Sheba Medical Center Tel Hashomer & Sackler School of Medicine, Tel-Aviv University, Ramat Gan, Israel PubMed articles Google scholar articles
Ella Fudim Department of Gastroenterology, Sheba Medical Center Tel Hashomer & Sackler School of Medicine, Tel-Aviv University, Ramat Gan, Israel PubMed articles Google scholar articles
Ofir Har-Noy Department of Gastroenterology, Sheba Medical Center Tel Hashomer & Sackler School of Medicine, Tel-Aviv University, Ramat Gan, Israel PubMed articles Google scholar articles
Uri Kopylov Department of Gastroenterology, Sheba Medical Center Tel Hashomer & Sackler School of Medicine, Tel-Aviv University, Ramat Gan, Israel PubMed articles Google scholar articles
Rami Eliakim Department of Gastroenterology, Sheba Medical Center Tel Hashomer & Sackler School of Medicine, Tel-Aviv University, Ramat Gan, Israel PubMed articles Google scholar articles
Shomron Ben-Horin Department of Gastroenterology, Sheba Medical Center Tel Hashomer & Sackler School of Medicine, Tel-Aviv University, Ramat Gan, Israel PubMed articles Google scholar articles
on behalf of ABIRISK consortium
Google scholar articles

Correspondence to Dr Shomron Ben-Horin, Gastroenterology Department, Sheba Medical Center, Tel Hashomer, Ramat Gan 52621, Israel; shomron.benhorin{at}gmail.com

View Full Text

Citation

Ungar B, Chowers Y, Yavzori M, et al

The temporal evolution of antidrug antibodies in patients with inflammatory bowel disease treated with infliximab

Gut 2014;63:1258-1264.

Publication history

Received May 11, 2013
Accepted August 22, 2013
First published September 16, 2013.

Online issue publication

April 18, 2016

Article Versions

Previous version (18 April 2016).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password